title: Characterization of molecules binding to the 70K N-terminal region of fibronectin by IFAST purification coupled with mass spectrometry.
abstract: Fibronectin (Fn) is a large glycoprotein present in plasma and extracellular matrix and is important for many processes. Within Fn the 70 kDa N-terminal region (70k-Fn) is involved in cell-mediated Fn assembly, a process that contributes to embryogenesis, development, and platelet thrombus formation. In addition, major human pathogens including Staphlycoccus aureus and Streptococcus pyogenes bind the 70k-Fn region by a novel form of protein-protein interaction called β-zipper formation, facilitating bacterial spread and colonization. Knowledge of blood plasma and platelet proteins that interact with 70k-Fn by β-zipper formation is incomplete. In the current study, we aimed to characterize these proteins through affinity purification. For this affinity purification, we used a novel purification technique termed immiscible filtration assisted by surface tension (IFAST). The foundation of this technology is immiscible phase filtration, using a magnet to draw paramagnetic particle (PMP)-bound analyte through an immiscible barrier (oil or organic solvent) that separates an aqueous sample from an aqueous eluting buffer. The immiscible barrier functions to remove unbound proteins via exclusion rather than dilutive washing used in traditional isolation methods. We identified 31 interactors from plasma, of which only seven were previously known to interact with Fn. Furthermore, five proteins were identified to interact with 70k-Fn from platelet lysate, of which one was previously known. These results demonstrate that IFAST offers advantages for proteomic studies of interacting molecules in that the technique requires small sample volumes, can be done with high enough throughput to sample multiple interaction conditions, and is amenable to exploratory mass spectrometric and confirmatory immuno-blotting read-outs.
authors.affiliation: Medical Scientist Training Program, University of Wisconsin, Madison, Wisconsin 53705, USA.
authors.forename: S Farshid
authors.initials: SF
authors.lastname: Moussavi-Harami
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Annis
authors.forename: Wenjiang
authors.initials: W
authors.lastname: Ma
authors.forename: Scott M
authors.initials: SM
authors.lastname: Berry
authors.forename: Emma E
authors.initials: EE
authors.lastname: Coughlin
authors.forename: Lindsay N
authors.initials: LN
authors.lastname: Strotman
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Maurer
authors.forename: Michael S
authors.initials: MS
authors.lastname: Westphall
authors.forename: Joshua J
authors.initials: JJ
authors.lastname: Coon
authors.forename: Deane F
authors.initials: DF
authors.lastname: Mosher
authors.forename: David J
authors.initials: DJ
authors.lastname: Beebe
mesh_terms: D001426:Bacterial Proteins / Q000302:isolation & purification* / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism; D001798:Blood Proteins / Q000302:isolation & purification* / Q000378:metabolism; D005353:Fibronectins / Q000097:blood* / Q000737:chemistry; D006801:Humans; D013058:Mass Spectrometry; D011485:Protein Binding; D040901:Proteomics; D013211:Staphylococcus aureus / Q000378:metabolism / Q000472:pathogenicity; D013297:Streptococcus pyogenes / Q000378:metabolism / Q000472:pathogenicity
chemical_list: D001426:Bacterial Proteins; D001798:Blood Proteins; D005353:Fibronectins